Heparanase, heparin and the coagulation system in cancer progression.
about
Determinants of leukocyte margination in rectangular microchannelsHeparanase regulates thrombosis in vascular injury and stent-induced flow disturbanceThe risk of cancer progression in women with gynecological malignancies and thrombophilic polymorphisms: a pilot case-control study.Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cellsA low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx.Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic AgentSuppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.Heparin impairs angiogenesis through inhibition of microRNA-10b.Heparanase Activates Antithrombin through the Binding to Its Heparin Binding SiteThe pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis.Non-anticoagulant heparins and inhibition of cancer.Structural and mechanistic classification of uronic acid-containing polysaccharide lyases.Low molecular weight heparins in the treatment of lung cancer.Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).Status and Prospects of Aptamers as Drug Components.RGD-xyloside conjugates prime glycosaminoglycans.A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma.In vitro effects of Apixaban on 5 different cancer cell lines.Perioperative events influence cancer recurrence risk after surgery.Heparanase level and procoagulant activity are reduced in severe sepsis.Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma.
P2860
Q27342087-7933F346-D758-490E-87AB-F03B8B84456EQ28264895-F4F15805-9510-4B1C-81BE-3235E1D89CC1Q33347978-B3E601F8-042A-406A-8377-8A1F597B1339Q33529871-8F8E86FF-1206-41A1-B510-22809563541CQ33614637-5D4A6D44-7868-479F-98E3-B7A94B18F03DQ33744134-FDB8DEEE-B7ED-4294-877B-2B9EFF684CB1Q33790809-B241FB3D-24AA-4DC3-9CC1-8E5E83885196Q33917661-5BE5526F-1363-49A4-A801-41CB5ED9D758Q35128227-CCEB5A29-1945-4545-80BD-77FE6B570C29Q36056653-41487F4C-A111-4114-97E9-665CC035E8DBQ37045970-E046C51C-F98B-476A-9CE4-1D9A758F7C51Q37379726-9B76CBD3-E4DD-4A04-870B-B4F4225CCAB5Q37784102-1575AFAF-A92F-4331-B811-8C5BC309B083Q37943009-DA875442-57BE-44D1-8EB9-6592EAD04634Q38333539-E8B278D7-575A-4210-BF7A-81B9ACD7348CQ38488502-FE8EB9A4-5ED7-4FB1-ADB4-ED51C54A1289Q39666438-6718AA0A-B8D8-4360-82B9-7C684FE08A9AQ41439920-9DFBAEDE-5B5F-42E7-B285-1C1D21BE56AAQ42375694-4315BF46-EB3C-4652-A346-AE15DCB120F1Q47217213-3E770FB3-7BE1-49F9-B62B-F71349984CE5Q47421732-8563CA4F-B7E4-414C-B40A-5B54A6936BFBQ55210200-C5ED4B5F-5E86-4DEF-9A26-346B8D0F2F5E
P2860
Heparanase, heparin and the coagulation system in cancer progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heparanase, heparin and the coagulation system in cancer progression.
@en
Heparanase, heparin and the coagulation system in cancer progression.
@nl
type
label
Heparanase, heparin and the coagulation system in cancer progression.
@en
Heparanase, heparin and the coagulation system in cancer progression.
@nl
prefLabel
Heparanase, heparin and the coagulation system in cancer progression.
@en
Heparanase, heparin and the coagulation system in cancer progression.
@nl
P2093
P1433
P1476
Heparanase, heparin and the coagulation system in cancer progression.
@en
P2093
Annamaria Naggi
Ben-Zion Katz
Benito Casu
Giangiacomo Torri
Israel Vlodavsky
Ram Sasisekharan
Yona Nadir
P304
P356
10.1016/S0049-3848(07)70139-1
P478
120 Suppl 2
P577
2007-01-01T00:00:00Z